Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage
NCT ID: NCT01400360
Last Updated: 2011-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
92 participants
INTERVENTIONAL
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage
NCT04512859
Stellate Ganglion Block and Cerebral Vasospasm
NCT04691271
Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)
NCT05268445
Brain Aneurysms: Utility of Cisternal Urokinase Irrigation
NCT04792944
Investigating the Tolerability and Feasibility of tVNS Following aSAH
NCT06374693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
invasive
After proof of perfusion relevant CVS in interventional therapy should be performed as best possible combination from TBA and intraarterial vasodilators additional to the conventional treatment.
Combination of TBA and intraarterial application of vasodilators
In the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated.
conventional
After proof of perfusion relevant CVS only conventional treatment should be performed (no intraarterial therapy).
Combination of TBA and intraarterial application of vasodilators
In the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combination of TBA and intraarterial application of vasodilators
In the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Perfusion relevant CVS
* Ability for MRI, DSA and intraarterial treatment
Exclusion Criteria
* SAH or ICH from AVM or flow associated aneurysm
* Non aneurismal SAH
* Relevant non spastic stenosis of brain supplying arteries
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dept. of Neurosurgery, Goethe-University Frankfurt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neurochirurgische Klinik, Universitätsklinik
Düsseldorf, , Germany
Department of Neurosurgery, Johann Wolfgang Goethe-University
Frankfurt am Main, , Germany
Neurochirurgische Klinik der Universität Ulm
Günzburg, , Germany
Klinik für Neurochirurgie, Universitätsklinikum
Jena, , Germany
Klinik für Neurochirurgie, Universitätsklinikum
Mannheim, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JohannWGUH_IMCVS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.